Alnylam finds belly fat gene and drug target in UK Biobank study
pharmaphorum
JULY 28, 2022
The RNA interference specialist says its researchers and collaborators have identified mutations in a gene called INHBE that are associated with protection against abdominal obesity and metabolic syndrome – a condition impacting more than 20% of adults worldwide. Image by Bruno /Germany from Pixabay .
52 
Let's personalize your content